Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

T KaragiannisAris LiakosE BekiariE AthanasiadouP PaschosD VasilakouM MainouM RikaP BouraD R MatthewsApostolos Tsapas

Published in: Diabetes, obesity & metabolism (2015)

Given their dosing scheme and overall efficacy and safety profile, once-weekly GLP-1 RAs are a convenient therapeutic option for use as add-on to metformin.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
wild type
insulin resistance